Myzotem 250mg Capsule
By Myzotem
Rx
5 Capsule in a Strip

Composition
Temozolomide(250mg)

Manufacturer - Mylan Pharmaceuticals Pvt Ltd
Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7th to 12th floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103

Expires on or after
July, 2026

liver
When it comes to Myzotem 250mg Capsule, caution is advised for individuals with severe liver disease. It may be necessary to adjust the dosage of the capsule in such cases, and consulting a healthcare provider is crucial. There is limited data regarding the use of Myzotem 250mg Capsule in patients with liver issues, and it is recommended not to adjust the dose for those with mild to moderate liver disease.

kidney
Myzotem 250mg Capsule is likely safe for patients with kidney disease. Dose adjustment may not be necessary, but consult your doctor. Exercise caution for those with severe kidney disease using this medication.

alcohol
Consult your doctor about consuming alcohol with Myzotem 250mg Capsule.

driving
Caution is advised when driving while using Myzotem 250mg Capsule as it may reduce alertness, cause vision changes, or lead to drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Myzotem 250mg Capsule may pose risks to the developing baby during pregnancy. Use only in life-threatening situations with doctor's approval. Consult your doctor before use.

breastfeeding
Caution should be taken when using Myzotem 250mg Capsule during breastfeeding, as it is considered unsafe. The drug has been linked to the potential risk of causing toxicity to the baby.
| Habit Forming | No |
| Chemical Class | Dacarbazine Derivative |
| Therapeutic Class | - |
| Action Class | Alkylating agent |
₹20000
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025
